Clinical Trial Update: PG2 Injection 500 mg in Acute Stroke Study (Pass) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of PG2 Injection 500 mg in acute stroke has completed successfully (Pass).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• PG2 Injection 500 mg

Snippet

Sponsor: China Medical University Hospital | Conditions: Acute Stroke | Phase 2 | Status: COMPLETED